High-throughput cell analysis and sorting technologies for clinical diagnostics and therapeutics

A number of theoretical and practical limits of high-speed flow cytometry/cell sorting are important for clinical diagnostics and therapeutics. Three applications include: (1) stem cell isolation with tumor purging for minimal residual disease monitoring and treatment, (2) identification and isolation of human fetal cells from maternal blood for prenatal diagnostics and in-vitro therapeutics, and (3) high-speed library screening for recombinant vaccine production against unknown pathogens.

[1]  J. Leary,et al.  High‐Speed Flow Cytometric Analysis and Sorting of Human Fetal Cells from Maternal Blood for Molecular Characterization , 1994, Annals of the New York Academy of Sciences.

[2]  M. Brenner,et al.  The contribution of marker gene studies to hemopoietic stem cell therapies , 1995, Stem cells.

[3]  James F. Leary,et al.  Chapter 20 Strategies for Rare Cell Detection and Isolation , 1994 .

[4]  A. Hagenbeek,et al.  Detection of Minimal Residual Disease in Acute Leukemia by Flow Cytometry a , 1986, Annals of the New York Academy of Sciences.

[5]  W. Anderson,et al.  Gene-marking to trace origin of relapse after autologous bone-marrow transplantation , 1993, The Lancet.

[6]  R. Krance,et al.  Use of gene marking in bone marrow transplantation. , 1996, Cancer detection and prevention.

[7]  R R Maronpot,et al.  Effects of fixation on RNA extraction and amplification from laser capture microdissected tissue , 1999, Molecular carcinogenesis.

[8]  Christos Stathopoulos,et al.  Display of heterologous proteins on the surface of microorganisms: From the screening of combinatorial libraries to live recombinant vaccines , 1997, Nature Biotechnology.

[9]  J A Hokanson,et al.  Theoretical basis for sampling statistics useful for detecting and isolating rare cells using flow cytometry and cell sorting. , 1997, Cytometry.

[10]  J F Leary,et al.  Strategies for rare cell detection and isolation. , 1994, Methods in cell biology.

[11]  M. Wigler,et al.  PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.

[12]  James F. Leary,et al.  High-speed cell classification systems for real-time data classification and cell sorting , 1997, Photonics West - Biomedical Optics.

[13]  J A Hokanson,et al.  Some theoretical and practical considerations for multivariate statistical cell classification useful in autologous stem cell transplantation and tumor cell purging. , 1999, Cytometry.

[14]  James F. Leary,et al.  New technology for ultrasensitive detection and isolation of rare cells for clinical diagnostics and therapeutics , 1995, Photonics West.

[15]  James F. Leary,et al.  New high-speed cell sorting methods for stem cell sorting and breast cancer cell purging , 1998, Photonics West - Biomedical Optics.

[16]  G. E. Cohn,et al.  Systems and Technologies for Clinical Diagnostics and Drug Discovery II , 1998 .

[17]  James F. Leary,et al.  Rare‐Event Detection and Sorting of Rare Cells , 2002 .

[18]  James F. Leary,et al.  High-speed real-time data classification and cell sorting using discriminant functions and probabilities of misclassification for stem cell enrichment and tumor purging , 1998, Photonics West - Biomedical Optics.

[19]  Feng He,et al.  Detection and isolation of single tumor cells containing mutated DNA sequences , 1999, Photonics West - Biomedical Optics.

[20]  James F. Leary,et al.  Real-time multivariate statistical classification of cells for flow cytometry and cell sorting: a data mining application for stem cell isolation and tumor purging , 1999, Photonics West - Biomedical Optics.

[21]  D. Epstein,et al.  Identification and isolation of differentially expressed genes from very small tissue samples. , 1999, BioTechniques.

[22]  James F. Leary,et al.  New methods for detection, analysis, and isolation of rare cell populations , 1996, Photonics West.